Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33,002 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes.
Kuemmerle-Deschner JB, Hachulla E, Cartwright R, Hawkins PN, Tran TA, Bader-Meunier B, Hoyer J, Gattorno M, Gul A, Smith J, Leslie KS, Jiménez S, Morell-Dubois S, Davis N, Patel N, Widmer A, Preiss R, Lachmann HJ. Kuemmerle-Deschner JB, et al. Among authors: smith j. Ann Rheum Dis. 2011 Dec;70(12):2095-102. doi: 10.1136/ard.2011.152728. Epub 2011 Aug 21. Ann Rheum Dis. 2011. PMID: 21859692 Clinical Trial.
Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study.
Koné-Paut I, Lachmann HJ, Kuemmerle-Deschner JB, Hachulla E, Leslie KS, Mouy R, Ferreira A, Lheritier K, Patel N, Preiss R, Hawkins PN; Canakinumab in CAPS Study Group. Koné-Paut I, et al. Arthritis Res Ther. 2011;13(6):R202. doi: 10.1186/ar3535. Epub 2011 Dec 9. Arthritis Res Ther. 2011. PMID: 22152723 Free PMC article. Clinical Trial.
Use of canakinumab in the cryopyrin-associated periodic syndrome.
Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, Leslie KS, Hachulla E, Quartier P, Gitton X, Widmer A, Patel N, Hawkins PN; Canakinumab in CAPS Study Group. Lachmann HJ, et al. N Engl J Med. 2009 Jun 4;360(23):2416-25. doi: 10.1056/NEJMoa0810787. N Engl J Med. 2009. PMID: 19494217 Free article. Clinical Trial.
Sex-dependent niche responses modulate steady-state and regenerative hematopoiesis.
Chaudhary R, Smith JNP, Tiwari R, Klein BR, Cordova BA, Petroze F, Richardson B, Broncano AV, Lee J, Parthasarathy PB, De Carvalho KIL, Cameron SJ, Lathia JD, Goodman WA, Cameron MJ, Desai AB. Chaudhary R, et al. Among authors: smith jnp. Exp Hematol. 2024 Jun 5:104247. doi: 10.1016/j.exphem.2024.104247. Online ahead of print. Exp Hematol. 2024. PMID: 38848877
Process of Engaging Community and Scientific Partners in the Development of the CIRCL-Chicago Study Protocol.
Smith JD, Carroll AJ, Sanuade OA, Johnson R, Abramsohn EM, Abbas H, Ahmad FS, Eggleston A, Lazar D, Lindau ST, McHugh M, Mohanty N, Philbin S, Pinkerton EA, Rosul LL, Merle JL, Tedla YG, Walunas TL, Davis P, Kho A. Smith JD, et al. Ethn Dis. 2024 Apr 24;DECIPHeR(Spec Issue):18-26. doi: 10.18865/ed.DECIPHeR.18. eCollection 2023 Dec. Ethn Dis. 2024. PMID: 38846735
33,002 results
You have reached the last available page of results. Please see the User Guide for more information.